Calcineurin inhibitors and cardiac hypertrophy

Lancet

Volumn 353, Issue 9161, 1999, Pages 1290-1292

  Force, T ^a   Rosenzweig, A ^a   Choukroun, G ^a   Hajjar, R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

CELL SIZE; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; NOTE; PRIORITY JOURNAL;

EID: 0033577538     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)90016-8     Document Type: Note

References (17)

1. JD Molkentin JR Lu CL Antos A calcineurin-dependent transcriptional pathway for cardiac hypertrophy Cell 93 1998 215 228
2. B Pitt Regression of left ventricular hypertrophy in patients with hypertension: blockade of the renin-angiotensin-aldosterone system Circulation 98 1998 1987 1989
3. A Rao C Luo PG Hogan Transcription factors of the NFAT family: regulation and function Annu Rev Immunol 15 1997 707 747
4. MA Sussman HW Lim N Gude Prevention of cardiac hypertrophy in mice by calcineurin inhibition Science 281 1998 1690 1693
5. T Meguro C Hong K Asai Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure Circ Res 84 1999 735 740
6. Z Luo K-G Shyu A Gualberto K Walsh Calcineurin inhibitors and cardiac hypertrophy Nat Med 4 1998 1092 1093
7. JG Muller S Nemoto M Laser BA Carabello DR Menick Calcineurin inhibition and cardiac hypertrophy Science 282 1998 1007
8. W Zhang RC Kowal F Rusnak RA Sikkink EN Olson RG Victor Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats Circ Res 84 1999 722 728
9. B Ding RL Price TK Borg EO Weinberg PF Halloran BH Lorell Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin Circ Res 84 1999 729 734
10. JD Molkentin Calcineurin inhibition and cardiac hypertrophy Science 282 1998 1007
11. T Force CM Pombo JA Avruch JV Bonventre JM Kyriakis Stress-activated protein kinases in cardiovascular disease Circ Res 78 1996 947 953
12. P Sugden A Clerk Stress-responsive mitogen-activated protein kinases (c-Jun N-terminal kinases and the p38 mitogen-activated protein kinases) in the myocardium Circ Res 83 1998 345 352
13. Y Wang S Huang VP Sah Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family J Biol Chem 273 1998 2161 2168
14. Y Wang B Su VP Sah JH Brown J Han KR Chien Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH-2-terminal kinase in ventricular muscle cells J Biol Chem 273 1998 5423 5426
15. G Choukroun R Hajjar JV Bonventre JM Kyriakis A Rosenzweig T Force Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy J Clin Invest 102 1998 1311 1320
16. G Choukroun R Hajjar A Rosenzweig T Force The stress-activated protein kinases mediate cardiac hypertrophy Circulation 98 Suppl I 1998 I-69
17. B Su E Jacinot H Masahiko T Kallunki M Karin Ben-Neriah JNK is involved in signal integration during costimulation of T lymphocytes Cell 77 1994 727 736